期刊文献+

宫内发育迟缓胎儿和巨大儿胎盘表皮生长因子受体表达的变化及与胎盘绒毛病理的关系 被引量:3

The relationship of change of IUGR and huge infant EGFR expression and pathology
下载PDF
导出
摘要 研究胎儿宫内发育迟缓(IUGR)和巨大儿患者胎盘上表皮生长因子受体(EGFR)的表达与正常妊娠胎 盘比较是否有差异,及分析其变化与胎盘绒毛发育是否有关。60例胎盘组织标本均取自足月妊娠胎盘,于分娩后立即取 得,4%中性甲醛缓冲液固定。用免疫组织化学SP法对胎盘上EGFR进行测定。阳性结果及绒毛面密度和末梢绒毛血管 大小的分析和测量用多功能真彩色病理图像分析系统进行。结果,IUGR儿胎盘上EGFR的表达较正常对照组明显增加 (P<0.001),而巨大儿组则无明显改变(P>0.05)。IUGR胎盘末梢绒毛血管数及血管与绒毛横面积之比均明显减少(P <0.01);而在巨大儿组与对照组比较,两者均无显著性差异(P>0.05,P=0.05)。IUGR组和巨大儿组胎盘绒毛面密度 与对照组比较均无显著性差异(P>0.05)。IUGR儿胎盘上EGFR表达增加可能与其胎盘绒毛发育不良有关。提示 EGFR在胎儿胎盘的生长发育过程中及IUGR的病理过程中起重要作用。 Compared IUGR and huge infant EGFR expression with normal preghant and analysed the change if or not were related with growth 60 cases organization samples were all got from pure month pregnant after childbirth, fixed with 4% neuter formaldehyde buffer solution EGFR were determined by immunohistachemistry SP method. The positive result, density and the last blood vessel size were analyzed and determined by polyfunction color pathology photo analysis system. The results were: compared with normal control, IUGR EGFR expression was signicantly increased (PRO<0.001 ), but huge infant group was no signicantly change(P>0. 05). The propotion of IUGR last blood vessel number and transverse area was decreased signicantly(p<0. 01), but huge infant group was compared with control group, Neither of them had signicant difference (P>0.05.P= 0. 05). Compared with control group, density of IUGR group and huge infant group had no signicant difference (P>0. 05). The increasing of IUGR EGFR expression perhaps was related with inadequate growth; It was suggested that EGFR could has important effect on the infant growth and development and IUGR pathology process.
出处 《中国妇幼保健》 CAS 2000年第1期42-44,共3页 Maternal and Child Health Care of China
关键词 胎盘 宫内发育迟缓 巨大儿 EGFR 绒毛 EGFR IUGR Huge infant
  • 相关文献

共引文献1

同被引文献25

  • 1张建鸿,谢雪玲,黄绍坤,罗淑贞,温燕云,谭梅珍,彭蔓蕾.妊娠期糖代谢异常性巨大儿与成纤维细胞生长因子的关系[J].中国优生与遗传杂志,2006,14(12):70-71. 被引量:5
  • 2魏志新,张丽珠,李美芝,杨池荪.促超排卵周期表皮生长因子对人卵泡发育的调节[J].中华妇产科杂志,1997,32(2):87-89. 被引量:9
  • 3谢幸,苟文丽.妇产科学.北京:人民卫生出版社,2013:133.
  • 4Siega-Riz AM, Viswanathan M, Moos MK ,et al. A systematic Review of outcomes of maternal gain according to the Institute of Medicine recomenda-tions: birthwcight, growth, and PostPartum weight retention. Am J Obstet Gyneco1,2009 ,4 :339-344.
  • 5Gaudet L, Wen SW, Walker M. The combined effect of maternal obesity and fetal macrosomia on pregnancy outcomes. J Obstet Gynaecol Can ,2014,6:776-784.
  • 6Legardeur H, Girard G, Joumy N, et al. Factors predictive of macrosomia in pregnancies with a positive oral glucose challenge test: importance of fasting plasma glucose. Diabetes Metab, 2014, 40:43-48 .
  • 7Soslow RA, Dannenberg ALl, Rush D, et al. Cox-2 is expressed in humanpul- monary, colonic, andmammary tumors, Cancer,2000,89 : 2637 -2645.
  • 8Under N, Lahat Y, Kogan A, et al. blacrosomic newborns of non- diabetic mothers : anthropometfic measurements and neonatal complications. Arch Dis Child Fetal Neonatal Ed, 2014, 99: F353-358.
  • 9Jiao J, Dang Y, Yang Y, etal. Promoting reprogramming by FGF2 reveals that the exla'acellular matrix is a barrier for reprogramming fibroblasts to pluripote- ncy. Stem Cells ,2013,31:729-769.
  • 10Hill DJ,Tevaarwerk GJ, Caddell C,et al. Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: relationship to fetal and placental size. J Clin Endocrinol Metab, 1995,80:2626-2657 .

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部